Product Information

DOXYLAMINE-PYRIDOXINE 10-10 MG is a generic product labeled by Actavis Pharma, Inc., priced at $1.1455 per EA under NDC 00591213201. Its NADAC has been published 362 times since Sep 18, 2019.

FDA first approved this application on Aug 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXYLAMINE-PYRIDOXINE 10-10 MG

Doxylamine succinate and pyridoxine hydrochloride
$1.1455per EA

Strength

10; 10 mg/1; mg/1

NDC

00591213201

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205811

FDA Approved

8/19/2016

TE Code

AB

On Market Since

6/21/2019

Pharmacological Classes

Analogs/Derivatives [Chemical/Ingredient]
Antihistamine
Histamine Receptor Antagonists
Vitamin B 6 [Chemical/Ingredient]
Vitamin B6 Analog

Price Statistics

The NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has been published 362 times since Sep 18, 2019, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1455 per EA
All-time high$5.3468 (Sep 15, 2021)
All-time low$0.9736 (Jul 17, 2024)
52-week high$1.3056
52-week low$1.1365
Median price$2.1309
Average price$2.5976
Largest weekly change+68.5% (Jun 19, 2024)
Weeks tracked362
Tracking sinceSep 18, 2019

Price History

1W

+0.8%

1M

+0.8%

3M

-9.3%

6M

-4.5%

1Y

-11.6%

3Y

-34.2%

5Y

-78.6%

All

-77.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DOXYLAMINE-PYRIDOXINE 10-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for DOXYLAMINE-PYRIDOXINE 10-10 MG, manufactured by Actavis Pharma, Inc., is $1.1455 per EA (NDC 00591213201), effective Aug 19, 2026.

How has the price of DOXYLAMINE-PYRIDOXINE 10-10 MG changed over time?

Over the history we have for it, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has declined 77.6%. It has been tracked across 362 weekly CMS publications since Sep 18, 2019.

What are the highest and lowest recorded NADAC prices for DOXYLAMINE-PYRIDOXINE 10-10 MG?

Since Sep 18, 2019, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has ranged from a low of $0.9736 (Jul 17, 2024) to a high of $5.3468 (Sep 15, 2021), with a median of $2.1309 per EA.

Are there cheaper alternatives to DOXYLAMINE-PYRIDOXINE 10-10 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXYLAMINE-PYRIDOXINE 10-10 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXYLAMINE-PYRIDOXINE 10-10 MG?

DOXYLAMINE-PYRIDOXINE 10-10 MG (NDC 00591213201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.